Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combination of a CB1 receptor antagonist and of a product which activates dopaminergic neurotransmission in the brain, the pharmaceutical compositions comprising them and their use in the treatment of parkinson's disease

Combination of a CB1 receptor antagonist and of a product which activates dopaminergic neurotransmission in the brain, the pharmaceutical compositions comprising them and their use in the treatment of parkinson's disease

US Patent 7217705 · Granted May 15, 2007

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

6-pyrimidinyl-pyrimid-4-one derivative2013
6-pyrimidinyl-pyrimid-4-one derivative2012
Method for detecting Alzheimer's disease2010
Combination of a CB1 receptor antagonist and of sibutramine, the pharmaceutical 2006
Combination of a CB1 receptor antagonist and of a product which activates dopami2006
Combination of a CB1 receptor antagonist and of a product which activates dopami2006
Combination of a CB1 receptor antagonist and of a product which activates dopami2006
Combination of a CB1 receptor antagonist and of a product which activates dopami2006
Combination of a CB1 receptor antagonist and of sibutramine, the pharmaceutical 2006
Pet cushion cover2004
Use of pyridazino[4,5-b]indole-1-acetamide derivatives for preparing medicines f2002
Nestable pet bed2001